Share Price and Basic Stock Data
Last Updated: April 2, 2025, 8:43 pm
| PEG Ratio | -1.99 |
|---|
Competitors of Archean Chemical Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 5,351 Cr. | 839 | 919/454 | 2,389 | 15.2 | 0.00 % | 5.25 % | 4.55 % | 10.0 |
| Emmessar Biotech & Nutrition Ltd | 16.4 Cr. | 32.7 | 64.0/27.2 | 21.5 | 15.6 | 0.00 % | 11.4 % | 10.6 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 208 Cr. | 266 | 415/239 | 18.7 | 198 | 3.01 % | 26.6 % | 5.82 % | 10.0 |
| Archean Chemical Industries Ltd | 6,649 Cr. | 538 | 832/408 | 30.4 | 143 | 0.56 % | 25.8 % | 19.4 % | 2.00 |
| Alufluoride Ltd | 374 Cr. | 478 | 581/341 | 16.8 | 122 | 0.63 % | 25.1 % | 22.2 % | 10.0 |
| Industry Average | 5,592.88 Cr | 530.65 | 257.38 | 146.20 | 0.50% | 15.23% | 10.70% | 7.82 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 307 | 373 | 400 | 293 | 365 | 382 | 343 | 290 | 413 | 283 | 211 | 238 | 243 |
| Expenses | 190 | 212 | 239 | 175 | 205 | 188 | 208 | 195 | 267 | 195 | 139 | 162 | 158 |
| Operating Profit | 117 | 160 | 161 | 119 | 160 | 194 | 135 | 96 | 146 | 88 | 73 | 76 | 84 |
| OPM % | 38% | 43% | 40% | 40% | 44% | 51% | 39% | 33% | 35% | 31% | 34% | 32% | 35% |
| Other Income | 6 | 4 | 9 | 19 | 8 | 9 | 11 | 12 | 10 | 14 | 12 | -26 | 12 |
| Interest | 41 | 39 | 39 | 35 | 19 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 17 | 17 | 18 | 17 | 17 | 17 | 17 | 17 | 18 | 17 | 18 | 18 | 19 |
| Profit before tax | 66 | 107 | 113 | 86 | 131 | 182 | 125 | 88 | 136 | 82 | 65 | 30 | 75 |
| Tax % | 26% | 24% | 25% | 26% | 25% | 25% | 25% | 24% | 25% | 28% | 26% | 26% | 25% |
| Net Profit | 49 | 82 | 85 | 64 | 98 | 137 | 94 | 66 | 102 | 60 | 48 | 22 | 56 |
| EPS in Rs | 5.09 | 8.50 | 8.79 | 6.63 | 7.99 | 11.12 | 7.65 | 5.39 | 8.28 | 4.83 | 3.93 | 1.77 | 4.56 |
Last Updated: February 28, 2025, 3:29 pm
Below is a detailed analysis of the quarterly data for Archean Chemical Industries Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹243.00 Cr.. The value appears strong and on an upward trend. It has increased from 238.00 Cr. (Sep 2024) to ₹243.00 Cr., marking an increase of 5.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹158.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 162.00 Cr. (Sep 2024) to ₹158.00 Cr., marking a decrease of 4.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹84.00 Cr.. The value appears strong and on an upward trend. It has increased from 76.00 Cr. (Sep 2024) to ₹84.00 Cr., marking an increase of 8.00 Cr..
- For OPM %, as of Dec 2024, the value is 35.00%. The value appears strong and on an upward trend. It has increased from 32.00% (Sep 2024) to 35.00%, marking an increase of 3.00%.
- For Other Income, as of Dec 2024, the value is ₹12.00 Cr.. The value appears strong and on an upward trend. It has increased from -26.00 Cr. (Sep 2024) to ₹12.00 Cr., marking an increase of 38.00 Cr..
- For Interest, as of Dec 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Sep 2024) to ₹19.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹75.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Sep 2024) to ₹75.00 Cr., marking an increase of 45.00 Cr..
- For Tax %, as of Dec 2024, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Sep 2024) to 25.00%, marking a decrease of 1.00%.
- For Net Profit, as of Dec 2024, the value is ₹56.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Sep 2024) to ₹56.00 Cr., marking an increase of 34.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 4.56. The value appears strong and on an upward trend. It has increased from 1.77 (Sep 2024) to 4.56, marking an increase of 2.79.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 2:02 pm
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 439 | 566 | 608 | 741 | 1,130 | 1,441 | 1,330 | 975 |
| Expenses | 356 | 497 | 460 | 478 | 663 | 807 | 865 | 654 |
| Operating Profit | 83 | 69 | 148 | 262 | 467 | 634 | 464 | 321 |
| OPM % | 19% | 12% | 24% | 35% | 41% | 44% | 35% | 33% |
| Other Income | 6 | 121 | 8 | 14 | 13 | 44 | 47 | 12 |
| Interest | 102 | 114 | 122 | 130 | 162 | 97 | 10 | 8 |
| Depreciation | 73 | 47 | 52 | 55 | 67 | 69 | 70 | 72 |
| Profit before tax | -85 | 29 | -17 | 90 | 251 | 513 | 431 | 252 |
| Tax % | -7% | -41% | 105% | 26% | 25% | 25% | 25% | |
| Net Profit | -79 | 41 | -36 | 67 | 189 | 384 | 322 | 186 |
| EPS in Rs | -79.16 | 21.31 | -18.50 | 34.56 | 19.58 | 31.18 | 26.12 | 15.09 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 8% | 11% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 151.90% | -187.80% | 286.11% | 182.09% | 103.17% | -16.15% |
| Change in YoY Net Profit Growth (%) | 0.00% | -339.70% | 473.92% | -104.02% | -78.91% | -119.32% |
Archean Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 22% |
| TTM: | -32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 44% |
| 3 Years: | 67% |
| TTM: | -45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 34% |
| 3 Years: | 34% |
| Last Year: | 19% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 5:51 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 19 | 19 | 19 | 19 | 25 | 25 | 25 |
| Reserves | -38 | 24 | -12 | 55 | 243 | 1,408 | 1,682 | 1,740 |
| Borrowings | 968 | 754 | 854 | 904 | 897 | 69 | 39 | 36 |
| Other Liabilities | 316 | 439 | 568 | 457 | 372 | 254 | 246 | 232 |
| Total Liabilities | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,033 |
| Fixed Assets | 940 | 914 | 882 | 1,042 | 1,086 | 1,097 | 1,086 | 1,061 |
| CWIP | 0 | 9 | 193 | 19 | 17 | 33 | 21 | 18 |
| Investments | 0 | 0 | 47 | 41 | 16 | 215 | 347 | 422 |
| Other Assets | 316 | 314 | 308 | 332 | 412 | 410 | 537 | 533 |
| Total Assets | 1,256 | 1,237 | 1,430 | 1,434 | 1,532 | 1,756 | 1,991 | 2,033 |
Below is a detailed analysis of the balance sheet data for Archean Chemical Industries Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹1,740.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,682.00 Cr. (Mar 2024) to ₹1,740.00 Cr., marking an increase of 58.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹36.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 39.00 Cr. (Mar 2024) to ₹36.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹232.00 Cr.. The value appears to be improving (decreasing). It has decreased from 246.00 Cr. (Mar 2024) to ₹232.00 Cr., marking a decrease of 14.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹2,033.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,991.00 Cr. (Mar 2024) to ₹2,033.00 Cr., marking an increase of 42.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹1,061.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,086.00 Cr. (Mar 2024) to ₹1,061.00 Cr., marking a decrease of 25.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2024) to ₹18.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2024, the value is ₹422.00 Cr.. The value appears strong and on an upward trend. It has increased from 347.00 Cr. (Mar 2024) to ₹422.00 Cr., marking an increase of 75.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹533.00 Cr.. The value appears to be declining and may need further review. It has decreased from 537.00 Cr. (Mar 2024) to ₹533.00 Cr., marking a decrease of 4.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹2,033.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,991.00 Cr. (Mar 2024) to ₹2,033.00 Cr., marking an increase of 42.00 Cr..
Notably, the Reserves (₹1,740.00 Cr.) exceed the Borrowings (36.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -885.00 | -685.00 | -706.00 | -642.00 | -430.00 | 565.00 | 425.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 43 | 27 | 34 | 49 | 30 | 43 |
| Inventory Days | 830 | 238 | 999 | 532 | |||
| Days Payable | 1,035 | 398 | 1,689 | 415 | |||
| Cash Conversion Cycle | -183 | -116 | -663 | 34 | 49 | 30 | 160 |
| Working Capital Days | -70 | 9 | -34 | 31 | 52 | 50 | 56 |
| ROCE % | 3% | 13% | 24% | 39% | 46% | 26% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 4,400,000 | 1.12 | 278.74 | 1,373,373 | 2025-04-03 | 220.38% |
| SBI Multicap Fund | 4,094,476 | 1.77 | 259.39 | 1,373,373 | 2025-04-03 | 198.13% |
| DSP Small Cap Fund | 2,297,376 | 1.05 | 145.54 | 1,373,373 | 2025-04-03 | 67.28% |
| Nippon India Small Cap Fund | 1,373,373 | 0.19 | 87 | 1,373,373 | 2025-04-03 | 0% |
| HDFC Multi Cap Fund | 1,095,175 | 0.59 | 69.38 | 1,373,373 | 2025-04-03 | -20.26% |
| SBI Magnum Childrens Benefit Fund - Investment Plan | 700,000 | 2.76 | 44.35 | 1,373,373 | 2025-04-03 | -49.03% |
| Kotak Small Cap Fund - Regular Plan | 636,952 | 0.28 | 40.35 | 1,373,373 | 2025-04-03 | -53.62% |
| Quant Small Cap Fund | 496,073 | 0.2 | 31.43 | 1,373,373 | 2025-04-03 | -63.88% |
| ITI Multi Cap Fund | 159,111 | 1.2 | 10.08 | 1,373,373 | 2025-04-03 | -88.41% |
| Motilal Oswal Multi Asset Fund | 50,000 | 3.09 | 3.17 | 1,373,373 | 2025-04-03 | -96.36% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 25.90 | 34.66 | 18.22 |
| Diluted EPS (Rs.) | 25.87 | 34.59 | 18.22 |
| Cash EPS (Rs.) | 31.55 | 36.67 | 26.48 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 137.89 | 116.29 | 26.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 137.89 | 116.29 | 26.75 |
| Revenue From Operations / Share (Rs.) | 107.79 | 117.11 | 117.35 |
| PBDIT / Share (Rs.) | 41.00 | 55.04 | 49.78 |
| PBIT / Share (Rs.) | 35.30 | 49.46 | 42.84 |
| PBT / Share (Rs.) | 34.62 | 41.58 | 26.06 |
| Net Profit / Share (Rs.) | 25.85 | 31.09 | 19.54 |
| NP After MI And SOA / Share (Rs.) | 25.85 | 31.09 | 19.54 |
| PBDIT Margin (%) | 38.04 | 46.99 | 42.42 |
| PBIT Margin (%) | 32.75 | 42.23 | 36.50 |
| PBT Margin (%) | 32.11 | 35.50 | 22.20 |
| Net Profit Margin (%) | 23.98 | 26.54 | 16.64 |
| NP After MI And SOA Margin (%) | 23.98 | 26.54 | 16.64 |
| Return on Networth / Equity (%) | 18.74 | 26.73 | 73.02 |
| Return on Capital Employeed (%) | 22.67 | 38.44 | 30.43 |
| Return On Assets (%) | 15.51 | 21.79 | 12.29 |
| Long Term Debt / Equity (X) | 0.03 | 0.00 | 3.27 |
| Total Debt / Equity (X) | 0.03 | 0.01 | 3.28 |
| Asset Turnover Ratio (%) | 0.69 | 0.87 | 0.00 |
| Current Ratio (X) | 5.38 | 3.35 | 2.27 |
| Quick Ratio (X) | 4.44 | 2.37 | 1.58 |
| Inventory Turnover Ratio (X) | 0.32 | 0.31 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 17.37 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 14.23 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 82.63 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 85.77 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 59.80 | 6.99 | 2.97 |
| Interest Coverage Ratio (Post Tax) (X) | 38.70 | 4.95 | 2.16 |
| Enterprise Value (Cr.) | 8283.52 | 7995.88 | 0.00 |
| EV / Net Operating Revenue (X) | 6.23 | 5.55 | 0.00 |
| EV / EBITDA (X) | 16.37 | 11.81 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 6.22 | 5.56 | 0.00 |
| Retention Ratios (%) | 82.62 | 0.00 | 0.00 |
| Price / BV (X) | 4.86 | 5.60 | 0.00 |
| Price / Net Operating Revenue (X) | 6.22 | 5.56 | 0.00 |
| EarningsYield | 0.03 | 0.04 | 0.00 |
After reviewing the key financial ratios for Archean Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 25.90. This value is within the healthy range. It has decreased from 34.66 (Mar 23) to 25.90, marking a decrease of 8.76.
- For Diluted EPS (Rs.), as of Mar 24, the value is 25.87. This value is within the healthy range. It has decreased from 34.59 (Mar 23) to 25.87, marking a decrease of 8.72.
- For Cash EPS (Rs.), as of Mar 24, the value is 31.55. This value is within the healthy range. It has decreased from 36.67 (Mar 23) to 31.55, marking a decrease of 5.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 137.89. It has increased from 116.29 (Mar 23) to 137.89, marking an increase of 21.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 137.89. It has increased from 116.29 (Mar 23) to 137.89, marking an increase of 21.60.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 107.79. It has decreased from 117.11 (Mar 23) to 107.79, marking a decrease of 9.32.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 41.00. This value is within the healthy range. It has decreased from 55.04 (Mar 23) to 41.00, marking a decrease of 14.04.
- For PBIT / Share (Rs.), as of Mar 24, the value is 35.30. This value is within the healthy range. It has decreased from 49.46 (Mar 23) to 35.30, marking a decrease of 14.16.
- For PBT / Share (Rs.), as of Mar 24, the value is 34.62. This value is within the healthy range. It has decreased from 41.58 (Mar 23) to 34.62, marking a decrease of 6.96.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 25.85. This value is within the healthy range. It has decreased from 31.09 (Mar 23) to 25.85, marking a decrease of 5.24.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 25.85. This value is within the healthy range. It has decreased from 31.09 (Mar 23) to 25.85, marking a decrease of 5.24.
- For PBDIT Margin (%), as of Mar 24, the value is 38.04. This value is within the healthy range. It has decreased from 46.99 (Mar 23) to 38.04, marking a decrease of 8.95.
- For PBIT Margin (%), as of Mar 24, the value is 32.75. This value exceeds the healthy maximum of 20. It has decreased from 42.23 (Mar 23) to 32.75, marking a decrease of 9.48.
- For PBT Margin (%), as of Mar 24, the value is 32.11. This value is within the healthy range. It has decreased from 35.50 (Mar 23) to 32.11, marking a decrease of 3.39.
- For Net Profit Margin (%), as of Mar 24, the value is 23.98. This value exceeds the healthy maximum of 10. It has decreased from 26.54 (Mar 23) to 23.98, marking a decrease of 2.56.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 23.98. This value exceeds the healthy maximum of 20. It has decreased from 26.54 (Mar 23) to 23.98, marking a decrease of 2.56.
- For Return on Networth / Equity (%), as of Mar 24, the value is 18.74. This value is within the healthy range. It has decreased from 26.73 (Mar 23) to 18.74, marking a decrease of 7.99.
- For Return on Capital Employeed (%), as of Mar 24, the value is 22.67. This value is within the healthy range. It has decreased from 38.44 (Mar 23) to 22.67, marking a decrease of 15.77.
- For Return On Assets (%), as of Mar 24, the value is 15.51. This value is within the healthy range. It has decreased from 21.79 (Mar 23) to 15.51, marking a decrease of 6.28.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.03, marking an increase of 0.03.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.03. This value is within the healthy range. It has increased from 0.01 (Mar 23) to 0.03, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.69. It has decreased from 0.87 (Mar 23) to 0.69, marking a decrease of 0.18.
- For Current Ratio (X), as of Mar 24, the value is 5.38. This value exceeds the healthy maximum of 3. It has increased from 3.35 (Mar 23) to 5.38, marking an increase of 2.03.
- For Quick Ratio (X), as of Mar 24, the value is 4.44. This value exceeds the healthy maximum of 2. It has increased from 2.37 (Mar 23) to 4.44, marking an increase of 2.07.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.32. This value is below the healthy minimum of 4. It has increased from 0.31 (Mar 23) to 0.32, marking an increase of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 17.37. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 17.37, marking an increase of 17.37.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 14.23. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 14.23, marking an increase of 14.23.
- For Earning Retention Ratio (%), as of Mar 24, the value is 82.63. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 82.63, marking an increase of 82.63.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 85.77. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 85.77, marking an increase of 85.77.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 59.80. This value is within the healthy range. It has increased from 6.99 (Mar 23) to 59.80, marking an increase of 52.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 38.70. This value is within the healthy range. It has increased from 4.95 (Mar 23) to 38.70, marking an increase of 33.75.
- For Enterprise Value (Cr.), as of Mar 24, the value is 8,283.52. It has increased from 7,995.88 (Mar 23) to 8,283.52, marking an increase of 287.64.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.23. This value exceeds the healthy maximum of 3. It has increased from 5.55 (Mar 23) to 6.23, marking an increase of 0.68.
- For EV / EBITDA (X), as of Mar 24, the value is 16.37. This value exceeds the healthy maximum of 15. It has increased from 11.81 (Mar 23) to 16.37, marking an increase of 4.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 6.22. This value exceeds the healthy maximum of 3. It has increased from 5.56 (Mar 23) to 6.22, marking an increase of 0.66.
- For Retention Ratios (%), as of Mar 24, the value is 82.62. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 82.62, marking an increase of 82.62.
- For Price / BV (X), as of Mar 24, the value is 4.86. This value exceeds the healthy maximum of 3. It has decreased from 5.60 (Mar 23) to 4.86, marking a decrease of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 6.22. This value exceeds the healthy maximum of 3. It has increased from 5.56 (Mar 23) to 6.22, marking an increase of 0.66.
- For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Archean Chemical Industries Ltd:
- Net Profit Margin: 23.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.67% (Industry Average ROCE: 15.23%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.74% (Industry Average ROE: 10.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 38.7
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.4 (Industry average Stock P/E: 257.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.98%
About the Company - Qualitative Analysis
No data availabale for About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Industry not found | Address not found | Contact not found |
Management Data not Available
FAQ
What is the intrinsic value of Archean Chemical Industries Ltd?
Archean Chemical Industries Ltd's intrinsic value (as of 03 April 2025) is ₹678.46 — 26.11% higher the current market price of ₹538.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 6,649 Cr. market cap, FY2025-2026 high/low of ₹832/408, reserves of 1,740 Cr, and liabilities of 2,033 Cr.
What is the Market Cap of Archean Chemical Industries Ltd?
The Market Cap of Archean Chemical Industries Ltd is 6,649 Cr..
What is the current Stock Price of Archean Chemical Industries Ltd as on 03 April 2025?
The current stock price of Archean Chemical Industries Ltd as on 03 April 2025 is 538.
What is the High / Low of Archean Chemical Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Archean Chemical Industries Ltd stocks is ₹832/408.
What is the Stock P/E of Archean Chemical Industries Ltd?
The Stock P/E of Archean Chemical Industries Ltd is 30.4.
What is the Book Value of Archean Chemical Industries Ltd?
The Book Value of Archean Chemical Industries Ltd is 143.
What is the Dividend Yield of Archean Chemical Industries Ltd?
The Dividend Yield of Archean Chemical Industries Ltd is 0.56 %.
What is the ROCE of Archean Chemical Industries Ltd?
The ROCE of Archean Chemical Industries Ltd is 25.8 %.
What is the ROE of Archean Chemical Industries Ltd?
The ROE of Archean Chemical Industries Ltd is 19.4 %.
What is the Face Value of Archean Chemical Industries Ltd?
The Face Value of Archean Chemical Industries Ltd is 2.00.